Community helpers may boost kidney transplant access
NCT ID NCT06655857
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether community health workers and special training for doctors can help more kidney patients get on the transplant waitlist. Five patients will be assigned to either usual care or extra support from a community health worker who addresses social needs like housing or food. The goal is to see if this approach speeds up the waitlisting process.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Community health worker assistance and provider education
- What this could lead to
- If successful, this could show a way to help more kidney patients get on the transplant waitlist by addressing social needs and reducing bias.
- What could go wrong
- This is a very small pilot study with only 5 participants, so results may not apply to larger groups. It tests a process, not a treatment, so impact is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 5 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient inclusion: * Provision of signed and dated informed consent from the patient. * Stated willingness to comply with all study procedures and availability for the duration of the study. * Age 18 - 75 years * eGFR≤20 mL/min/1.73m2 or on maintenance in-center HD. * Receive kidney care at Mount Sinai, Einstein, Bellevue Hospital, NYU, or hemodialysis at a participating HD Center. * Community dwelling (i.e., not in a nursing home, currently incarcerated). * Speak English and/or Spanish. * Provider Inclusion: * Provision of signed and dated informed consent from the nephrologist. * Stated willingness to comply with all study procedures and availability for the duration of the study. Exclusion Criteria: * Patient Exclusion: * Absolute contraindications to KTx: * Self-reported or documented diagnosis of dementia, or inability to understand the study and complete informed consent. When the participant's understanding is unclear, the CRC will use a modified MOCA screener to determine eligibility. * Active malignancy (excluding local non-melanoma skin cancer, renal cell carcinoma \<5 cm, early thyroid cancer, and prostate cancer GS≤6). * Pregnancy (can be re-evaluated post-delivery). * Active infection. Patients excluded due to active infection will be evaluated at 30 days or after completing full treatment (whichever is later) to determine eligibility. Examples of active infection include: * Positive cultures or radiographic evidence of infection * Infected intravascular devices, such as tunneled catheters and pacemakers * Active histoplasmosis, cryptococcosis, tuberculosis (TB), and nontuberculous mycobacteria * Previously evaluated by KTx and not listed for specific medical reasons. * Patients previously evaluated and not listed will be carefully reviewed by site PI for eligibility * Already listed for KTx. * Patients on other types of dialysis other than in-center hemodialysis. * Self-identify as already engaged with a CHW at participating sites to address unmet social needs. * Planning to move out of the greater NY area in the next 1 year. * Provider Exclusion: * Planning to leave their respective institutions in the next 1 year
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Montefiore Einstein
NOT_YET_RECRUITINGThe Bronx, New York, 10467, United States
-
Mount Sinai Hospital
RECRUITINGNew York, New York, 10029, United States
-
NYU Langone Health
NOT_YET_RECRUITINGNew York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a breathing workout and walks help dialysis patients with irregular heartbeats?
- Can a deep breath and a hint of lemongrass take the sting out of dialysis needles?
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can a Patient's own kidney cells hold off dialysis?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can pedaling during dialysis make red blood cells more flexible?